eventscribe

The eventScribe Educational Program Planner system gives you access to information on sessions, special events, and the conference venue. Take a look at hotel maps to familiarize yourself with the venue, read biographies of our plenary speakers, and download handouts and resources for your sessions.

close this panel

SUBMIT FEEDBACKfeedback icon

Please enter any improvements, suggestions, or comments for the JSM Proceedings.

Comments


close this panel
support

Technical Support


Phone: (410) 638-9239

Fax: (410) 638-6108

GoToMeeting: Meet Now!

Web: www.CadmiumCD.com

Submit Support Ticket


close this panel
‹‹ Go Back

David Oakes

University of Rochester



‹‹ Go Back

Please enter your access key

The asset you are trying to access is locked for premium users. Please enter your access key to unlock.


Email This Presentation:

From:

To:

Subject:

Body:

←Back IconGems-Print

287 – Current and Future Challenges in Analyzing Composite Endpoints

On the Intransitivity of the Win Ratio

Sponsor: Lifetime Data Science Section
Keywords: cardiovascular trials, censored data, composite outcome, prioritized endpoints, survival analysis, win ratio

David Oakes

University of Rochester

Pocock et al. (2012) following Finkelstein and Schoenfeld (1999) popularized the win ratio for analysis of controlled clinical trials with multiple types of outcome event. The approach uses pairwise comparisons between patients in the treatment and control groups using a primary outcome, say time to death, with indeterminacies broken resolved where possible using a secondary outcome, say time to hospitalization. Preferences assigned by this method may not be transitive. Intransitivity occurs when potential follow-up time varies between patients and rankings based on primary events differ from those based on secondary events. We derive some general properties of win-ratio preferences and provide numerical illustrations under some simple models. Unless all follow-up times are equal, see Oakes (2016) intransitives are certain to occur in sufficiently large samples, but their overall frequency is low and there is no simple remediation of the problem.

"eventScribe", the eventScribe logo, "CadmiumCD", and the CadmiumCD logo are trademarks of CadmiumCD LLC, and may not be copied, imitated or used, in whole or in part, without prior written permission from CadmiumCD. The appearance of these proceedings, customized graphics that are unique to these proceedings, and customized scripts are the service mark, trademark and/or trade dress of CadmiumCD and may not be copied, imitated or used, in whole or in part, without prior written notification. All other trademarks, slogans, company names or logos are the property of their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, owner, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by CadmiumCD.

As a user you may provide CadmiumCD with feedback. Any ideas or suggestions you provide through any feedback mechanisms on these proceedings may be used by CadmiumCD, at our sole discretion, including future modifications to the eventScribe product. You hereby grant to CadmiumCD and our assigns a perpetual, worldwide, fully transferable, sublicensable, irrevocable, royalty free license to use, reproduce, modify, create derivative works from, distribute, and display the feedback in any manner and for any purpose.

© 2020 CadmiumCD